Lucy Abraham

2.9k total citations
98 papers, 2.0k citations indexed

About

Lucy Abraham is a scholar working on Pharmacology, Psychiatry and Mental health and Rheumatology. According to data from OpenAlex, Lucy Abraham has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 28 papers in Psychiatry and Mental health and 20 papers in Rheumatology. Recurrent topics in Lucy Abraham's work include Musculoskeletal pain and rehabilitation (20 papers), Menopause: Health Impacts and Treatments (17 papers) and Osteoarthritis Treatment and Mechanisms (13 papers). Lucy Abraham is often cited by papers focused on Musculoskeletal pain and rehabilitation (20 papers), Menopause: Health Impacts and Treatments (17 papers) and Osteoarthritis Treatment and Mechanisms (13 papers). Lucy Abraham collaborates with scholars based in United Kingdom, United States and France. Lucy Abraham's co-authors include Tara Symonds, Mark Morris, Kathryn May, Stanley E. Althof, Mona L. Martin, Michael A. Perelman, Anna Crossland, François Giuliano, Andrew G. Bushmakin and Joseph C. Cappelleri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and The Journal of Urology.

In The Last Decade

Lucy Abraham

90 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucy Abraham United Kingdom	22	887	588	408	355	355	98	2.0k
Rany Shamloul Egypt	29	1.6k 1.8×	521 0.9×	510 1.3×	161 0.5×	829 2.3×	77	2.3k
Michael A. Perelman United States	25	2.0k 2.2×	1.0k 1.8×	602 1.5×	255 0.7×	926 2.6×	63	2.5k
Beth A. Mohr United States	18	1.3k 1.4×	503 0.9×	587 1.4×	192 0.5×	1.7k 4.7×	34	2.9k
Dana DiBenedetti United States	20	371 0.4×	192 0.3×	89 0.2×	156 0.4×	385 1.1×	70	1.5k
John F. Steege United States	35	378 0.4×	288 0.5×	127 0.3×	450 1.3×	236 0.7×	86	3.0k
Hatta Sidi Malaysia	22	727 0.8×	516 0.9×	74 0.2×	172 0.5×	303 0.9×	69	1.4k
Sheri Fehnel United States	25	301 0.3×	182 0.3×	66 0.2×	85 0.2×	498 1.4×	80	2.2k
Shu‐Chen Wu United States	21	523 0.6×	239 0.4×	71 0.2×	107 0.3×	60 0.2×	38	1.7k
Shaloo Gupta United States	27	657 0.7×	284 0.5×	16 0.0×	174 0.5×	123 0.3×	81	2.0k
Zoë Hyde Australia	26	310 0.3×	142 0.2×	33 0.1×	65 0.2×	970 2.7×	51	2.2k

Countries citing papers authored by Lucy Abraham

Since Specialization

Citations

This map shows the geographic impact of Lucy Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Abraham more than expected).

Fields of papers citing papers by Lucy Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Abraham. The network helps show where Lucy Abraham may publish in the future.

Co-authorship network of co-authors of Lucy Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Abraham. A scholar is included among the top collaborators of Lucy Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Abraham. Lucy Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Terwindt, Gisela M., Jessica Ailani, Lucy Abraham, et al.. (2025). Underdiagnosis and impact of menstrual migraine in real‐world clinical practice: A real‐world survey. Headache The Journal of Head and Face Pain. 65(8). 1413–1427.

Powell, Lauren, et al.. (2025). Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial. The Journal of Headache and Pain. 26(1). 1–1. 1 indexed citations

Pozo‐Rosich, Patricia, Paweł Lisewski, Abdullah Nabi Aslan, et al.. (2025). A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications. Cephalalgia. 45(11). 2235436434–2235436434.

Ashina, Messoud, Peter McAllister, Charly Gaul, et al.. (2025). Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial. Cephalalgia. 45(11). 2235440354–2235440354.

Lipton, Richard B., Astrid Gendolla, Lucy Abraham, et al.. (2024). Relative frequency, characteristics, and disease burden of patients with migraine unsuitable for triptan treatment: A systematic literature review. Headache The Journal of Head and Face Pain. 65(1). 164–179. 3 indexed citations

Schnitzer, Thomas J., Philip G. Conaghan, Francis Bérenbaum, et al.. (2024). Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis. Advances in Rheumatology. 64(1). 31–31. 1 indexed citations

Abraham, Lucy, Rachel Russell, Lídia Sànchez-Riera, et al.. (2023). Quantifying The Burden of Persistent Musculoskeletal Pain in Employees at Rolls-Royce in The United Kingdom. Journal of Occupational and Environmental Medicine. 65(6). e424–e434.

Fullen, Bróna M., Bart Morlion, Steven J. Linton, et al.. (2022). Management of chronic low back pain and the impact on patients’ personal and professional lives: Results from an international patient survey. Pain Practice. 22(4). 463–477. 20 indexed citations

Hunter, David J., Thomas J. Schnitzer, Jerry Hall, et al.. (2022). Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab. SHILAP Revista de lepidopterología. 4(3). 100294–100294. 1 indexed citations

10.

Perrot, Serge, Michael J. Doane, Dena H. Jaffe, et al.. (2021). Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries. Pain Practice. 22(3). 359–371. 14 indexed citations

11.

Abraham, Lucy, et al.. (2021). Comparing the Fiscal Consequences of Controlled and Uncontrolled Osteoarthritis Pain Applying a UK Public Economic Perspective. Journal of health economics and outcomes research. 8(1). 127–136. 1 indexed citations

12.

Akazawa, Manabu, Kanae Togo, Nozomi Ebata, et al.. (2019). <p>Patterns of drug treatment in patients with osteoarthritis and chronic low back pain in Japan: a retrospective database study</p>. Journal of Pain Research. Volume 12. 1631–1648. 27 indexed citations

13.

Clayton, Anita H., Eunhee Hwang, Susan G. Kornstein, et al.. (2015). Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder. International Clinical Psychopharmacology. 30(6). 307–315. 4 indexed citations

14.

Abraham, Lucy, L. Humphrey, Rob Arbuckle, et al.. (2014). Qualitative cross-cultural exploration of breast symptoms and impacts associated with hormonal treatments for menopausal symptoms to inform the development of new patient-reported measurement tools. Maturitas. 80(3). 273–281. 9 indexed citations

15.

Abraham, Lucy, JoAnn V. Pinkerton, Michael Messig, et al.. (2014). Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Maturitas. 78(3). 212–218. 10 indexed citations

16.

Abraham, Lucy, et al.. (2013). A Phase 2a Multicenter, Double-Blind, Placebo-Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP-866,087 (a High-Affinity Mu-Opioid Receptor Antagonist) in Premenopausal Women Diagnosed with Female Sexual Arousal Disorder (FSAD). The Journal of Sexual Medicine. 10(10). 2484–2496. 9 indexed citations

17.

Symonds, Tara, et al.. (2012). Sexual Function Questionnaire: Further Refinement and Validation. The Journal of Sexual Medicine. 9(10). 2609–2616. 32 indexed citations

18.

Lasch, Kathryn, et al.. (2011). Development of a next day functioning measure to assess the impact of sleep disturbance due to restless legs syndrome: The restless legs syndrome-next day impact questionnaire. Sleep Medicine. 12(8). 754–761. 15 indexed citations

19.

Laithwaite, Heather, et al.. (2009). Recovery After Psychosis (RAP): A Compassion Focused Programme for Individuals Residing in High Security Settings. Behavioural and Cognitive Psychotherapy. 37(5). 511–526. 137 indexed citations

20.

Abraham, Lucy, Asha Hareendran, Ian Mills, et al.. (2004). Development and validation of a quality-of-life measure for men with nocturia. Urology. 63(3). 481–486. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact